Total Clarity Wealth Management, Inc. Axsome Therapeutics, Inc. Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$30.7 - $43.36 $6,784 - $9,582	-221 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$19.91 - $68.26 $4,400 - $15,085	221 New	221 $7,000
Q2 2021 Jul 26, 2021	SELL	$50.63 - $73.5 $36,808 - $53,434	-727 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$55.91 - $81.44 $40,646 - $59,206	727 New	727 $41,000
Q1 2020 Apr 24, 2020	SELL	$41.2 - $101.31 $10,094 - $24,820	-245 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$16.71 - $106.24 $4,093 - $26,028	245 New	245 $25,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.77B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.